|
1 |
26 03 2025 |
CDSCO develop national drugs licensing system portal for Pharma manufacturers to adopt updated Schedule M |
Medical Dialogues |
India |
|
2 |
26 03 2025 |
Shut Non-compliant Firms: Panel demands strict action aganist counterfeit drugs |
Medical Dialogues |
India |
|
3 |
26 03 2025 |
Penza region keen on pharma sector: Minister Read more at: https://www.deccanherald.com/india/penza-region-keen-on-pharma-sector-minister-3462950 |
Deccan Herald |
India |
|
4 |
26 03 2025 |
Big Pharma faces heat as India records 307 drug pricing violations |
Business Today |
India |
|
5 |
26 03 2025 |
PCI warns of tough action against inspectors who don't follow its guidelines during inspection |
Pharmabiz |
India |
|
6 |
26 03 2025 |
Bulk drug parks should be made ready by March, 2026 invariably, says Parliamentary Panel |
Pharmabiz |
India |
|
7 |
26 03 2025 |
Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines |
PR NEWS WIRE |
Philippines |
|
8 |
25 03 2025 |
Indian pharma working to strengthen PMS & supply chain transparency for OTC drugs |
Pharmabiz |
India |
|
9 |
25 03 2025 |
Government discontinues RoDTEP Scheme benefits for AAs, SEZs, and EOUs |
Pharmabiz |
India |
|
10 |
25 03 2025 |
Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel |
Pharmabiz |
India |
|
11 |
25 03 2025 |
No drug manufactured in TN was found either spurious or counterfeit in last three years: MN Sridhar |
Pharmabiz |
India |
|
12 |
25 03 2025 |
J.P. Morgan prefers India-focussed pharma firms amid looming US tariffs |
Health world(Economic Times) |
India |
|
13 |
25 03 2025 |
Trump to announce auto, aluminum and pharma tariffs ‘very soon’ |
Business Line |
USA |
|
14 |
24 03 2025 |
Ayush and herbal products exports report growth of 10% in first nine months of FY25 |
Pharmabiz |
India |
|
15 |
24 03 2025 |
Gujarat FDCA wages war against illegal sale of narcotic and psychotropic drugs |
Pharmabiz |
India |
|
16 |
24 03 2025 |
Unable to meet demand for drugs as high production cost makes adhering to DPCO unviable: industry |
Pharmabiz |
India |
|
17 |
24 03 2025 |
Parliamentary Panel asks govt to expand scope of NLEM to include more life-saving medicines |
Pharmabiz |
India |
|
18 |
24 03 2025 |
CDSCO launches online system for SMEs to submit application for extension on Revised Schedule M implementation |
Pharmabiz |
India |
|
19 |
24 03 2025 |
Mankind Pharma gets CDSCO panel nod for Bioequivalence study of Resmetirom Tablets |
Medical Dialogues |
India |
|
20 |
24 03 2025 |
Unlicensed premises operating Illegally without drug License ,stocks worth Rs.43000 seized |
Medical Dialogues |
India |
